FDA
approval
· 2016-07-15
FDA Approved: PHOTREXA CROSS-LINKING KIT — Original Application (Glaukos Corporation)
Summary
The FDA approved Photrexa Cross-Linking Kit (riboflavin 5-phosphate ophthalmic) from Glaukos to perform corneal collagen cross-linking for slowing progression o…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for PHOTREXA CROSS-LINKING KIT (RIBOFLAVIN 5-PHOSPHATE OPHTHALMIC)